doi:10.1016/S0090-4295(84)80075-8Mark S. SolowayElsevier Inc.UrologySoloway M.S., Systemic therapy for superficial bladder cancer, Urology, 1984; 23 (4 Suppl) : 88-93.
Figure 2. Potential systemic therapy de-escalation strategies in selected patients with advanced ovarian cancer. BRCA, BReast CAncer genes; CHT, chemotherapy; HRD, homologous recombination deficiency; IDS, interval debulking surgery; PARPi, poly(ADP-ribose) polymerase inhibitors; PDS, primary debulking ...
Breast cancer can serve as a good model for economic evaluation of cancer treatment because of the broad range of treatment options and objectives it encompasses, and also because well defined benefits can be achieved. The cost utility of contemporary adjuvant therapy strategies, specifically chemothera...
Transitional cell carcinoma of the bladder and urinary tract (urothelial cancer) is one of the most common cancers diagnosed in North America. About 75 % of urothelial cancer is superficial, non-invasive Ta and Tl disease. In the majority of cases superf
Nancy U. Lin, MD, provides clinical insights on the treatment of patients with breast cancer brain metastases and discusses the advantages and disadvantages of systemic therapy vs radiation therapy for this population. Nancy U. Lin, MD As the treatment of patients with central nervous system (...
et al. Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 Randomized Clinical Trial. J. Clin. Oncol. 35, 56–62 (2017). Article PubMed Google Scholar National Comprehensive Cancer Network...
Systemic Therapy of Kidney Cancer: Tyrosine Kinase Inhibitors, Antiangiogenesis or IL-2?Ziya Kirkali, MD; Emre Tüzel, MD Disclosures Future Oncol. 2009;5(6):871-888. 0Molecular Pathways for RCC Therapeutics The improved understanding of RCC biology has been accompanied by an increased ...
systemic therapycontraindicationsclinical trialsreal-world datadecision-makingefficacyadverse eventsquality of lifePatients with head and neck cancer often present with complex challenges due to a substantial comorbidity burden, including substance use disorders, and the tumor's location in regions that are ...
Adjuvant systemic therapy in breast cancer: A review. Eur J Cancer Clin Oncol 1983; 19:1753-1770.H.T., Mouridsen. (1993) Adjuvant systemic therapy in breast cancer. European Journal of Cancer 29 , 595-598 /Mouridsen HT. Adjuvant systemic therapy in breast cancer. Eur J Cancer. 1993;...
Neoadjuvant therapy refers to the systemic treatment of breast cancer prior to definitive surgical therapy. Neoadjuvant therapy is administered with the objective of improving surgical outcomes in patients with breast cancer for whom a primary surgical a